EBM Technologies Inc is engaged in picture archiving and communication systems. Its products include EBM diagnostic and reviewing station, EBM storage and utility server, and EBM breast imaging for PACS. The company develops and markets medical information technology solutions; and provides to the health sector.
1988
116
LTM Revenue n/a
LTM EBITDA n/a
$16.6M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
EBM Technologies has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, EBM Technologies achieved revenue of $8.5M and an EBITDA of $0.7M.
EBM Technologies expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See EBM Technologies valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $6.2M | $8.5M | XXX | XXX | XXX |
Gross Profit | $5.6M | $4.7M | XXX | XXX | XXX |
Gross Margin | 89% | 55% | XXX | XXX | XXX |
EBITDA | $0.1M | $0.7M | XXX | XXX | XXX |
EBITDA Margin | 2% | 8% | XXX | XXX | XXX |
Net Profit | $0.1M | -$0.4M | XXX | XXX | XXX |
Net Margin | 2% | -5% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, EBM Technologies's stock price is TWD 22 (or $1).
EBM Technologies has current market cap of TWD 688M (or $20.8M), and EV of TWD 548M (or $16.6M).
See EBM Technologies trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$16.6M | $20.8M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, EBM Technologies has market cap of $20.8M and EV of $16.6M.
EBM Technologies's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate EBM Technologies's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for EBM Technologies and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $16.6M | XXX | XXX | XXX |
EV/Revenue | 2.0x | XXX | XXX | XXX |
EV/EBITDA | 23.8x | XXX | XXX | XXX |
P/E | 321.5x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | 4.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpEBM Technologies's NTM/LTM revenue growth is n/a
EBM Technologies's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $45K for the same period.
Over next 12 months, EBM Technologies's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate EBM Technologies's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for EBM Technologies and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 36% | XXX | XXX | XXX | XXX |
EBITDA Margin | 8% | XXX | XXX | XXX | XXX |
EBITDA Growth | 511% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
Opex per Employee | $45K | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 21% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 22% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 18% | XXX | XXX | XXX | XXX |
Opex to Revenue | 62% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
Clarity Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
Cyclopharm | XXX | XXX | XXX | XXX | XXX | XXX |
Healius | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
EBM Technologies acquired XXX companies to date.
Last acquisition by EBM Technologies was XXXXXXXX, XXXXX XXXXX XXXXXX . EBM Technologies acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was EBM Technologies founded? | EBM Technologies was founded in 1988. |
Where is EBM Technologies headquartered? | EBM Technologies is headquartered in Taiwan. |
How many employees does EBM Technologies have? | As of today, EBM Technologies has 116 employees. |
Is EBM Technologies publicy listed? | Yes, EBM Technologies is a public company listed on ROCO. |
What is the stock symbol of EBM Technologies? | EBM Technologies trades under 8409 ticker. |
When did EBM Technologies go public? | EBM Technologies went public in 2012. |
Who are competitors of EBM Technologies? | Similar companies to EBM Technologies include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm. |
What is the current market cap of EBM Technologies? | EBM Technologies's current market cap is $20.8M |
What is the current revenue growth of EBM Technologies? | EBM Technologies revenue growth between 2023 and 2024 was 36%. |
Is EBM Technologies profitable? | Yes, EBM Technologies is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.